About Swelife-ATMP

Swelife-ATMP is a project within the strategic innovation program Swelife, a common investment of Vinnova, Formas and the Swedish Energy Agency. Swelife-ATMP focuses on development of the knowledge, processes, competencies and support functions required to take an ATMP from the preclinical stage to the patient. This involves identifying ATMP specific gaps in law, ethics and regulation, as well as identifying specific needs within healthcare, business, research and industry. The Swelife-ATMP project drives collaboration between authorities, healthcare, academia, investors and industry and aims to increase visibility, awareness and engagement within the ATMP field and with the public/patients.

The national strategic project Swelife-ATMP has ended and the final report is now available. See link below:

Swelife ATMP final report Jan 2022

 

The Swelife-ATMP project drives collaboration between authorities, healthcare, academia, investors and industry and aims to increase visibility, awareness and engagement within the ATMP field and with the public/patients.

Check out the ATMP regulatory guide developed by our SDP1 Regulatory Project! Assisting you in getting from the pre-clinical phase to clinical trials

Related content

Become a partner

Help us to revolutionise healthcare! Build a partnership with our organisation.

Sign up to our newsletter

The ATMP newsletter is a quarterly newsletter updating on Swedish ATMP developments.